5-(1,1,2,2,2-Pentafluoroethyl)-2-Propyl-3-[[4-[2-(2H-Tetrazol-5-Yl)Phenyl]Phenyl]Methyl]Imidazole-4-Carboxylic Acid

CAS: 124750-95-4

Ref. 3D-FP103189

Produktinformation

• Name: 5-(1,1,2,2,2-Pentafluoroethyl)-2-Propyl-3-[[4-[2-(2H-Tetrazol-5-Yl)Phenyl]Phenyl]Methyl]Imidazole-4-Carboxylic Acid
• Synonyme: 2-Propyl-4-pentafluoroethyl-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)imidazole-5-carboxylic acid, 1H-Imidazole-5-carboxylic acid, 4-(pentafluoroethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, 4-(pentafluoroethyl)-2-propyl-1-{[2'-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid

Beschreibung

5-(1,1,2,2,2-Pentafluoroethyl)-2-Propyl-3-[[4-[2-(2H-Tetrazol-5-Yl)Phenyl]Phenyl]Methyl]Imidazole-4-Carboxylic Acid (FFF) is a synthetic substrate that acts as a pressor agent. It has been shown to be membrane permeable and stable in human serum and liver. FFF has been used in clinical studies for the treatment of congestive heart failure. The drug binds to angiotensin receptors and blocks the binding of angiotensin II, which leads to an increase in blood pressure. 5-(1,1,2,2,2-Pentafluoroethyl)-2-Propyl-3-[4-[(4S)-4-(4′Hydroxyphenyl)Butanoyl]-1Hpyrazolo[3

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 506.43 g/mol
• Formel: C₂₃H₁₉F₅N₆O₂
• Reinheit: Min. 95%
• InChl: InChI=1S/C23H19F5N6O2/c1-2-5-17-29-19(22(24,25)23(26,27)28)18(21(35)36)34(17)12-13-8-10-14(11-9-13)15-6-3-4-7-16(15)20-30-32-33-31-20/h3-4,6-11H,2,5,12H2,1H3,(H,35,36)(H,30,31,32,33)
• InChI Key: InChIKey=RQGDXPDTZWGCQI-UHFFFAOYSA-N
• SMILES: CCCc1nc(C(F)(F)C(F)(F)F)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1